| abstract |
The present invention relates in particular to the use of a compound of formula (I) and a pharmaceutically acceptable salt thereof as an active substance for the inhibition or prevention of acute and / or chronic neurological disorders:n n n Formula In n n n n n n n Wheren n n R represents halogen or lower alkyl,n n n n represents 0 to 3,n n n R 1 is lower alkyl; Cycloalkyl; Benzyl optionally substituted by hydroxy, halogen, lower alkoxy or lower alkyl; Benzoyl optionally substituted by amino, lower alkylamino or lower dialkylamino; Acetyl or cycloalkyl-carbonyl;n n n Denotes an aromatic 5-membered moiety which is linked through an N atom and further contains 1 to 3 N atoms in addition to the linking N atom. |